Immunohistochemical Separation of Follicular Variant of Papillary Thyroid Carcinoma from Follicular Adenoma
- 1 January 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in Endocrine Pathology
- Vol. 17 (3), 213-224
- https://doi.org/10.1385/ep:17:3:213
Abstract
The accurate diagnosis of differentiated thyroid tumors is very important for clinical management of patients. The histopathological distinction between some types of differentiated thyroid tumors can be very difficult even for experienced pathologists. We used immunohistochemical markers from published data obtained from DNA expression profiling, tissue microarray analysis, and immunohistochemistry to analyze a series of 157 thyroid tumors and 5 normal thyroids. These analyses showed that several antibodies were useful in distinguishing follicular adenomas from follicular variant of papillary thyroid carcinomas including HBME-1, CITED 1, galectin-3, cytokeratin 19, and S100A4 (p<0.0001). A combination of markers consisting of a panel of HBME-1, galectin-3, and CK19 or a panel of HBME-1, CITED1, and galectin-3 was usually most effective in distinguishing follicular adenoma from follicular variant of papillary thyroid carcinoma. Because individual tumors may not express some of these markers, the use of a panel of antibodies is recommended. These results indicate that some individual antibodies or a panel of antibodies combined with histopathological analysis can be useful in separating follicular adenoma (FA) from follicular variant of papillary thyroid carcinoma (FVPTC).This publication has 30 references indexed in Scilit:
- Usefulness of HBME‐1, cytokeratin 19 and galectin‐3 immunostaining in the diagnosis of thyroid malignancyHistopathology, 2005
- RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumorsLaboratory Investigation, 2005
- Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumorsLaboratory Investigation, 2005
- Expression of Matrix Metalloproteinases and Their Specific Inhibitors in Normal and Different Human Thyroid Tumor Cell LinesThyroid®, 2004
- CITED1 Protein Expression Suggests Papillary Thyroid Carcinoma in High Throughput Tissue Microarray-Based StudyThyroid®, 2004
- S100A4 Expression Is an Early Event of Papillary Carcinoma of the ThyroidOncology, 2004
- Tissue Microarrays Are an Effective Quality Assurance Tool for Diagnostic ImmunohistochemistryLaboratory Investigation, 2002
- Clinical Significance of Molecular Expression Profiles of Hürthle Cell Tumors of the Thyroid Gland Analyzed via Tissue MicroarraysThe American Journal of Pathology, 2002
- Immunohistochemical study of thyroid peroxidase in normal, hyperplastic, and neoplastic human thyroid tissuesCancer, 1991
- Expression of monoclonal antibody-defined epitopes of keratin 19 in human tumours and cultured cellsEuropean Journal of Cancer and Clinical Oncology, 1986